High-cost conditions drive 30 percent of employer spend yet represent 1-2 percent of the employed population. Quest understands these issues well – the company is not only a large self-insured employer with more than 45,000 employees, it also provides the Blueprint for Wellness solution for other companies, encompassing biometric wellness screenings, and services that connect employees to the care they need and help intervene for health improvement.Employers continue to confront annual increases in the cost of health benefits. The event brought together healthcare providers, health plans, pharmaceutical executives, leading technology and solutions companies, academia, and government to highlight advances in population health.Quest’s Jay Wohlgemuth, MD, SVP and Chief Medical Officer, Research & Development, Medical and Employee Health, Steven Goldberg, MD, MBA, VP, Chief Health Officer, Health & Wellness, Maren Fragala, PhD, Director, HealthyQuest, and Wendi Mader, Director, Marketing and Strategy, Health & Wellness were on hand to present learnings from the company’s vast population health data through a Mini Summit titled: Personalized Medicine, Machine Learning, and Genomics: a Clinical Approach to Employer Population Health & Wellbeing.Experts from Quest explored population health issues facing employers and ways to improve workforce wellness. Recently, members of Quest Diagnostics as well as some of our collaborators participated in the 18th Population Health Colloquium in Philadelphia from March 19-21, 2018. While population health practices have traditionally been used for managed care, they also can be applied to all areas of healthcare, from employer wellness to precision medicine. Analysis of trends in populations can identify gaps that, if corrected, can result in better outcomes or lower costs. Vitamin D: Screening to see if the body has enough Vitamin D present in the bloodstream to maintain bone health.Quest shares how its data insights improve employee health at the 18th Population Health ColloquiumInsights from population health programs are increasingly influential to the practice of healthcare and the management of patient health.Often used to confirm with tobacco-free incentives. Cotinine (serum or oral swab): Screening to confirm use of nicotine substances.Thyroid-stimulating hormone (TSH): Screening to detect abnormal thyroid function which can be indicative of hypothyroidism, hyperthyroidism, or other health issues. Prostate-specific antigen (PSA): Screening to detect prostate cancer risk.SARS-CoV-2 (COVID-19) antibody: Screening to provide employees knowledge about their immune response to a recent or prior infection of COVID-19.High-sensitivity CRP (hsCRP): Screening for inflammation in the body, which can be an early indicator of heart disease.eGFR: Screening for estimated glomerular filtration rate (eGFR) can alert individuals to their chronic kidney disease (CKD) risk before CKD progresses to an advanced stage.Hemoglobin A1c (HbA1c) : Screening for HbA1c provides a look at blood glucose levels over a 2-3 month timespan, and can alert screening participants with normal glucose measurements to type 2 diabetes risk.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |